Merck
Signal active
Investment Firm
Overview
Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.
The company is driven by a mission to discover, develop, and provide innovative products and services that save and improve lives around the world. Merck delivers vaccines, medications, and consumer and animal health products that can help millions around the world.
Merck was founded in 1891 and is headquartered in Kenilworth, NJ.
Highlights
Founded
1891
Industry
Biotechnology
Employees
10001+
Investment
24
Lead Investment
6
Exits
10
Stages
Late Stage Venture, Private Equity, Early Stage Venture, Seed
Investor Type
N/A
Location
United States, North America
Contact Information
Social
Profile Resume
Merck, established in 1891 and headquartered in United States, North America., specializes in Late Stage Venture, Private Equity, Early Stage Venture, Seed investments across Biotechnology, Developer Platform, Therapeutics, Life Science, Health Care, Pharmaceutical, Financial Services, Venture Capital, Semiconductor, Software Engineering. The organization boasts a portfolio of 24 investments, with an average round size of $82.5M and 10 successful exits. Their recent investments include VAXIMM, Sunstone Life Science Ventures, BB Biotech Ventures, BioMedPartners, eASIC. The highest investment round they participated in was $58.0B. Among their most notable exits are VAXIMM and Sunstone Life Science Ventures. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Employees
Investment portfolio
Merck has made 24 investments. Their most recent investment was on May 27, 2024, when Friends of Puerto Rico raised $190.0K.
investments
24
Diversity investments
2
Lead investments
6
Number of exits
10
Investments
24
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| Mar 30, 2022 | Qure AI | Artificial Intelligence (AI) | 40.0M |
| Mar 27, 2023 | Mamotest | Health Care | 3.3M |
| May 04, 2023 | Prognos Health | Analytics | 23.3M |
| May 27, 2024 | Friends of Puerto Rico | Non Profit | 190.0K |
Qure AIExits
10
Funding Timeline
Funding rounds
24
Investors
2
Funds
1
Funding Rounds
24
Merck has raised 24 rounds. Their latest funding was raised on May 27, 2024 from a Grant - Friends of Puerto Rico round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| Mar 30, 2022 | Series C - Qure AI | - | 40.0M | - |
| Mar 27, 2023 | Seed Round - Mamotest | - | 3.3M | - |
| May 04, 2023 | Venture Round - Prognos Health | - | 23.3M | - |
| May 27, 2024 | Grant - Friends of Puerto Rico | - | 190.0K | - |
Investors
2
Merck is funded by 2 investor(s). Private Capital Advisors and Gavi, the Vaccine Alliance Kantor are the most recent investors.
| Investor Name | Lead Investor | Funding Round | Money Raised |
|---|---|---|---|
Gavi, the Vaccine Alliance | Yes | Venture Round - Merck | 5.0M |
Private Capital Advisors | Yes | Post-IPO Equity - Merck | 586.0K |
Gavi, the Vaccine AllianceFund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.